Where does Jim Sullivan, Ph.D. work?

Jim Sullivan, Ph.D. is Venture Partner at OrbiMed and Executive at Vanqua Bio.

What does Jim Sullivan, Ph.D. invest in?

Jim Sullivan, Ph.D. invests in Biotech.

What boards does Jim Sullivan, Ph.D. sit on?

Jim Sullivan, Ph.D. holds tracked board seats at Aliada, Vanqua Bio.

Where did Jim Sullivan, Ph.D. go to school?

Jim Sullivan, Ph.D. studied at Trinity College Dublin (Doctor of Philosophy (Ph.D.), Biochemistry).

Jim Sullivan, Ph.D.

Investor

Venture Partner at OrbiMed · Executive at Vanqua Bio

Greater Chicago Area

About

Jim Sullivan joined OrbiMed as a Venture Partner in 2019 and serves as CEO of portfolio company Vanqua Bio, which develops therapeutics for neurological conditions such as Parkinson's disease. He previously was Vice President of Research at AbbVie, overseeing research across oncology, immunology, neurology, hepatitis C, and cystic fibrosis, and has advanced more than 100 compounds into clinical development. He holds a bachelor's degree and Ph.D. in biochemistry from Trinity College Dublin, completed postdoctoral research in neurobiology at Northwestern University, and is an adjunct faculty member there.

Invests in

Biotech

Executive at Vanqua Bio

Intro paths

→

In turn, Jim can intro founders to Vanqua Bio's investors below.

Vanqua Bio's investors · 2

OrbiMedNew York · $1M – $75M checks · since 2021 Pontifax Venture CapitalHerzeliya · $6.3M – $128M checks

Experience

Vanqua BioChief Executive Officercurrent2019 — presentChicago
OrbiMedVenture Partnercurrent2019 — presentGreater New York City Area
Northwestern UniversityAdjunct Professor, Department of Pharmacologycurrent2009 — presentChicago
AbbVieVice President Global Discovery2013 — 2018Abbott Park, Chicago
AbbottVice President Global Pharmaceutical Discovery2008 — 2012Abbott Park, IL
AbbottVice President, Neuroscience Discovery2001 — 2008Abbott Park Chicago
AbbottDirector Neuroscience Discovery1997 — 2000Abbott Park, Chicago
AbbottProject Leader1995 — 1997Neuroscience and Urology Research
AbbottSr Research Scientist, Neuroscience Discovery1991 — 1993Abbott Park
Nova PharmaceuticalsResearch Scientist1990 — 1991Baltimore, Maryland Area
Northwestern UniversityPostdoctoral Fellow, Department of Neurobiology1987 — 1990Evanston, Illinois

Skills & more

Life Sciences3Biotechnology2Clinical Development1Drug Discovery1Clinical TrialsBiopharmaceuticals3Oncology1Immunology1Regulatory Affairs1Neuroscience1BiologicsChemistry

+2 more

Molecular PharmacologyPharmaceutical Industry

From Jim's professional profile.

Investments

Board seats

AliadaVanqua Bio

Per the firm's website.

Colleagues at OrbiMed

Venture Partner at OrbiMed

Andrew P. Kanarek, CFA, CIPM

Frequently asked questions

Who is Jim Sullivan, Ph.D.?: Jim Sullivan joined OrbiMed as a Venture Partner in 2019 and serves as CEO of portfolio company Vanqua Bio, which develops therapeutics for neurological conditions such as Parkinson's disease. He previously was Vice President of Research at AbbVie, overseeing research across oncology, immunology, neurology, hepatitis C, and cystic fibrosis, and has advanced more than 100 compounds into clinical development. He holds a bachelor's degree and Ph.D. in biochemistry from Trinity College Dublin, completed postdoctoral research in neurobiology at Northwestern University, and is an adjunct faculty member there.
Where does Jim Sullivan, Ph.D. work?: Jim Sullivan, Ph.D. is Venture Partner at OrbiMed and Executive at Vanqua Bio.
What does Jim Sullivan, Ph.D. invest in?: Jim Sullivan, Ph.D. invests in Biotech.
What boards does Jim Sullivan, Ph.D. sit on?: Jim Sullivan, Ph.D. holds tracked board seats at Aliada, Vanqua Bio.
Where did Jim Sullivan, Ph.D. go to school?: Jim Sullivan, Ph.D. studied at Trinity College Dublin (Doctor of Philosophy (Ph.D.), Biochemistry).